Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Royal Prima Tbk's Other Operating Expense for the
three
months ended in Mar. 2026 was Rp15,043 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was Rp58,675 Mil.
PT Royal Prima Tbk's quarterly Other Operating Expense
increased
from Sep. 2025 (Rp12,788 Mil) to Dec. 2025 (Rp17,741 Mil) but then
declined
from Dec. 2025 (Rp17,741 Mil) to Mar. 2026 (Rp15,043 Mil).
PT Royal Prima Tbk's annual Other Operating Expense
declined
from Dec. 2023 (Rp57,177 Mil) to Dec. 2024 (Rp56,085 Mil) but then
increased
from Dec. 2024 (Rp56,085 Mil) to Dec. 2025 (Rp57,370 Mil).
PT Royal Prima Tbk Other Operating Expense Related Terms
PT Royal Prima Tbk Other Operating Expense Historical Data
* Premium members only.
The historical data trend for PT Royal Prima Tbk's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp58,675 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of Rp58,675 Mil mean?
PT Royal Prima Tbk (ISX:PRIM) has a Other Operating Expense of Rp58,675 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on PT Royal Prima Tbk and its competitors.
Is PT Royal Prima Tbk's Other Operating Expense too high?
PT Royal Prima Tbk's current Other Operating Expense is Rp58,675 Mil. Overall, PT Royal Prima Tbk has a GF Score™ of 72/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Royal Prima Tbk's Other Operating Expense compare to HCA and THC?
PT Royal Prima Tbk's Other Operating Expense of Rp58,675 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on PT Royal Prima Tbk and its competitors. PT Royal Prima Tbk's current Other Operating Expense is Rp58,675 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Royal Prima Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Royal Prima Tbk (ISX:PRIM) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp81.60, compared to a current price of Rp94.00 — trading 15.2% above its estimated fair value. The current Other Operating Expense is Rp58,675 Mil. PT Royal Prima Tbk's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For PT Royal Prima Tbk (ISX:PRIM), the current Other Operating Expense is Rp58,675 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Royal Prima Tbk (ISX:PRIM) Overvalued in 2026?
Based on GuruFocus' analysis, PT Royal Prima Tbk stock appears to be overvalued.
The current stock price of Rp94.00 is trading 15.2% above its estimated GF Value™ of Rp81.60.
GuruFocus considers PT Royal Prima Tbk to be Modestly Overvalued.
Key valuation signals for ISX:PRIM:
Other Operating Expense: Rp58,675 Mil
GF Value™: Rp81.60 vs. price of Rp94.00 (15.2% above fair value)
No single metric tells the full story. See the ISX:PRIM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Royal Prima Tbk is engaged in health services which consist of the provision of hospital services, polyclinics, hall treatment, maternity hospital, and specialist hospital. It has three geographic segments: RSU Royal Prima, RS Royal Prima Jambi, and Rumah Sakit Marelan. The company generates the majority of its revenue from RSU Royal Prima segment. The company generates revenue from Drugs and medical supplies, doctors' and nurses' fees, Hospital facilities, Room services, and Others.
72GF Score
Get the complete analysis for ISX:PRIM
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:PRIM has been successfully added to your 
